Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for Type 2 Diabetes Mellitus
NCT01413035Phase 2Unknown
- Sponsor
- Shandong University
- Start
- Jul 2011
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in type 2 diabetes mellitus (T2DM), sponsored by Shandong University. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01413035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01413035.